Irritable bowel syndrome

4 trials 3 recruiting MedDRA PT
4 Registered trials
3 Recruiting
4 Unique sponsors
4 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
A Gastroenterology (ATC A) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Phase III: 2 Phase II: 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

2 trials
  • Biocodex Commercial
    SACCHAROMYCES BOULARDII CNCM I-745 LYOPHILIZED
    2024-520276-10-00 2 countries 2025 n=365
    Recruiting
  • Assistance Publique Hopitaux De Paris Academic
    ALLOGENEIC FAECAL MICROBIOTA, POOLED; PLACEBO
    2024-516099-13-00 1 country 2025 n=150
    Recruiting

Phase II

2 trials
  • Cannabibs Sp. z o.o. Commercial
    CANNABIDIOL
    2024-514685-39-00 1 country 2025 n=35
    Recruiting
  • Polyclinique De L'europe Academic
    IMP not specified
    2023-506950-18-00 1 country n=27
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Cannabibs Sp. z o.o. Commercial 1 Phase II 1
Biocodex Commercial 1 Phase III 1
Polyclinique De L'europe Academic 1 Phase II 0
Assistance Publique Hopitaux De Paris Academic 1 Phase III 1
New trials by year
2025
3
← All indication landscapes